510(k) Report

510(k) · Cleared

Cleared

ExaStim® Stimulation System (EXA-001); ExaStim® Stimulation System (EXA-011); ReCure® Electrode Pad (PAD-003); ReCure® Electrode Pad (PAD-013)

K252893510(k) TraditionalCleared Mar 27, 2026197-day reviewClass II21 CFR 890.5851

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Aneuvo · SDO Transcutaneous Electrical Spine Stimulator To Improve Skeletal Muscle Strength And Sensation

Cleared on Mar 27, 2026 as substantially equivalent to DEN240014 (Onward Medical, Inc., 2024) after a 197-day review. Its family tree reaches back 1 generation to 2024.

Decided
Mar 27, 2026
Review
197 days
Class
Class II
Product code
SDO
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to DEN240014 (2024). No later device cites it as a predicate yet.

DEN240014 · ARC-EX System · Onward Medical, Inc. · 20240
  1. Root · 1 generation backDEN240014 ARC-EX SystemOnward Medical, Inc. · 2024
  2. This deviceK252893 ExaStim® Stimulation System (EXA-001); ExaStim® Stimulation System…Aneuvo · 2026
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1DEN240014ARC-EX SystemOnward Medical, Inc.2024—
0 (this device)K252893ExaStim® Stimulation System (EXA-001); ExaStim® Stimulation System (EXA-011)…Aneuvo2026—
FIG. 1 — Lineage of K252893, 2024–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in SDO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new SDO device

  1. #1 K253638 xStep (xStep)score 11.2 · 1 generation · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*DEN240014ARC-EX System
Summary page 8
…(Predicate) Comparison System (Subject) (DEN240014) The ExaStim Stimulation System is a portable, non-invasive,…
Onward Medical, Inc.2024—
†K132422Pals Platinum Neurostimulation ElectrodesAxelgaard Mfg. Co., Ltd.2014—

Also cleared against DEN240014: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • 2 other devices also cite its predicate DEN240014.

How does its category compare?

All SDO devices

SDO Transcutaneous Electrical Spine Stimulator To Improve Skeletal Muscle Strength And Sensation: FDA decisions, review times, recalls and adverse event reports over 20 years. 2026, this device’s year, is highlighted.

FDA decisions per year · SDO

2so far in 2026, the most since 2007

2024: 12025: 12026 (partial year): 2
2007high 2 (2026) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · SDO

Too few SDO 510(k)s in any year since 2007 to give a median.

Recalls per year · SDO

No recall names SDO since 2007.

Adverse event reports per year · SDO

No MAUDE report names SDO since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20220—00
20230—00
20241—00
20251—00
20262—0—

What is it indicated for?

The ExaStim Stimulation System is indicated for the improvement of hand sensation and strength in individuals between 18 and 75 years old who present with a chronic, non-progressive neurological deficit resulting from an incomplete spinal cord injury, when used in conjunction with functional task practice.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K252893: ExaStim® Stimulation System (EXA-001); ExaStim® Stimulation System (EXA-011); ReCure® Electrode Pad (PAD-003); ReCure® Electrode Pad (PAD-013).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K252893

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026